Xanthine derivatives, and their use in pharmaceutical compositions
US4451449A · kind A · utility
4Cited by
1References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 29, 1981 |
| Grant date | May 29, 1984 |
| Priority date | — |
| Expiry date | Jun 29, 2001 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Ketals of 1-(1,3-dialkylxanthin-7-yl)propan-2-ones are of use in the treatment of vascular disorders. A representative embodiment is 2-methyl-2-(1,3-dibutylxanthin-7-ylmethyl)-1,3-dioxalane.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.